These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21323891)

  • 41. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
    Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
    Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.
    Uckun FM; Qazi S; Ozer Z; Garner AL; Pitt J; Ma H; Janda KD
    Br J Haematol; 2011 Jun; 153(6):741-52. PubMed ID: 21517817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells.
    Schwemmlein M; Stieglmaier J; Kellner C; Peipp M; Saul D; Oduncu F; Emmerich B; Stockmeyer B; Lang P; Beck JD; Fey GH
    Leukemia; 2007 Jul; 21(7):1405-12. PubMed ID: 17495978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.
    Marin V; Kakuda H; Dander E; Imai C; Campana D; Biondi A; D'Amico G
    Exp Hematol; 2007 Sep; 35(9):1388-97. PubMed ID: 17656004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
    Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
    Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant human CD19-ligand protein as a potent anti-leukaemic agent.
    Uckun FM; Sun L; Qazi S; Ma H; Ozer Z
    Br J Haematol; 2011 Apr; 153(1):15-23. PubMed ID: 21323891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia.
    Fulda S
    Br J Haematol; 2009 May; 145(4):441-54. PubMed ID: 19298593
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.